Endpoints News

Endpoints News

Startup to run CAR-T trials in China		Read in browser

Thank you for reading, dupa dupackia!

basic

UPGRADE

M T Wed Th F

27 May, 2026

ASCO is about to deliver some make-or-break cancer data. Join us to figure out which pipeline bets will pay off. Get your spot now.

Spotlight

Today at 11:30 am: Jeremy Levin sounds the alarm on biotech

news

Kardigan readies Nasdaq IPO to back three cardio drugs

Exclusive: Waypoint Bio raises $20M to run three CAR-T trials in China

In Focus

Can AI do scientific research? Billions are pouring in to find out

May 28

11:30 am ET

From signal to strategy: The future of systemic viral immunotherapy in GI tumors and Oncolytics Biotech

sponsored by OncolyticsBiotech

Jun 11

11:00 am ET

Data-driven manufacturing: Enhancing process robustness across sites

sponsored by Samsung Biologics

LGBTQ+ diversity drives innovation in biopharma — but transgender and non-binary professionals face rising challenges. Endpoints is going live with our fourth annual special report celebrating the honorees giving voice and visibility while forging ahead across life sciences. Join us.

ENDPOINTS PHARMA

Three CRLs later, Outlook says FDA will sign off on its version of Avastin for wet AMD

Astellas’ five-year plan includes chasing record sales and cost cuts

Three vaccine biotechs to be bought by Lilly for up to $3.8B

in case you missed it

1.

Lilly reports new data on PCSK9 base editing gene therapy from Verve buyout

2.

Exclusive: Protuoso gets $9.5M to build the next hub-and-spoke antibody developer

3.

News Briefing

Cartesian secures funding to 'accelerate' launch; Editas sells $125M in stock

4.

Ebola Vaccine From Oxford Covid Team Nears Production for Trials

5.

Strep A vaccine gets $140M backing

Reynald Castaneda

.

Join us on YouTube at 11:30 am ET today in a conversation with industry vet Jeremy Levin on what’s keeping biotech execs up at night — China, MFN and more hot topics. See you then!

.

Reynald Castaneda

Deputy Editor, Endpoints News

2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com